Replies to post #123241 on Biotech Values

[DewDiligence]

SNY presents additional Lemtrada data from CARE-MS I trial:

http://finance.yahoo.com/news/Alemtuzumab-Lemtrada-bw-4094658172.html?x=0&.v=1

Lemtrada is the (proposed) brand name for Campath when the drug is used in MS.